An acid-labile interferon-or (IFN-ct) exists in IFN produced in human peripheral leukocytes with Sendai virus. This activity was found in fractions of molecular weights about 100000 (100K), 58K and 44K. The IFN activity in the 100K fraction was neutralized with anti-HulFN-~ serum alone, but activity in the 58K and 44K fractions was neutralized only by a mixture of anti-HulFN-ct and anti-HulFN-fl sera.
diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) (Hooks et al., 1979) and with acquired immune deficiency syndrome (AIDS) (DeStefano et al., 1982) . IFNs from SLE and AIDS patients were specifically neutralized with an antibody against human leukocyte interferon (HuIFN-c0 and showed as much antiviral activity on bovine cells as did HulFN-c~ (Preble et al., 1982) . However, IFN from these patients was inactivated by treatment at pH 2 or at 56 °C for 60 min, like HulFN-y. This acid-labile IFN was considered to be a subtype of HulFN-~ by Preble & Friedman (1983) .
The DNA cloning technique has revealed that HulFN-~ produced in human peripheral leukocytes infected with Sendai virus consists of more than 10 subtypes. However, only subtypes HulFN-ctA and HulFN-ctD have been characterized in detail biologically and physicochemically. It is not clear whether the acid-labile HulFN-ct found in autoimmune disease belongs to one of the subtypes of HulFN-ct.
Acid-labile IFNs have also been reported to be produced in monocyte-depleted T cells by induction with Newcastle disease virus (NDV) (Wiranowska-Stewart & Stewart, 1981) . Vil~ek et al. (1980) also showed that human lymphocytes stimulated with Corynebacterium parvum produced acid-labile IFN In the present study, it was found that acid-labile IFN was detected in HulFN-~ preparations made in human leukocytes by induction with Sendai virus. The biological and physicochemical properties of this IFN have been compared with HulFN-ct, HulFN-/~ and HulFN-~,.
IFN was assayed by the dye-uptake method using human amnion (FL) cells grown in Eagle's MEM supplemented with 5 ~o newborn calf serum (NCS) and vesicular stomatitis virus (New Jersey strain) propagated in FL cells as challenge virus. The reciprocal of the IFN concentration which reduced the absorbance at 546 nm by 50~ was expressed as laboratory IFN units, and these values were calibrated against the MRC reference IFN standard preparation (code 69/19) and expressed as international units (IU).
For determination of antigenic types, IFN preparations were mixed with anti-IFN serum or MEM as control at a 1:1 ratio, and incubated at 37 °C in a humidified 5~ CO: atmosphere for 1 h. The residual IFN activity in the mixture was determined on FL cells. Anti-HulFN-ct serum, which neutralized 365 IU of HulFN-~ completely at 640-fold dilution, was obtained from rabbits immunized with HulFN-ct produced in BALL-1 cells. Anti-HulFN-fl serum, which neutralized 140 IU of HulFN-fl completely at 1280-fold dilution, was kindly supplied by Dr S. Kobayashi, Basic Research Laboratories, Toray Industries Inc., Kamakura, Japan. There was no cross-reactivity between anti-HulFN-~ and anti-HulFN-fl sera. Anti-HulFN-~ serum, which neutralized 174 IU of HulFN-~ completely at 320-fold dilution, was kindly supplied by Dr Y. Terano, Suntory Co., Osaka, Japan.
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Crude HulFN-~ produced in human peripheral leukocytes by induction with Sendai virus (Nita, 1982 ) was kindly provided by Dr H. Nita, Kyoto Red Cross Blood Center, Kyoto, Japan. Briefly, human peripheral leukocytes were isolated from the buffy coat by adding 0.83% ammonium sulphate, and the density of leukocyte suspension was adjusted to 1 x 107 cells/ml. The leukocytes were infected with Sendai virus at a dose of 200 haemagglutinating units/ml. After inoculation at 37 °C for 24 h, the supernatants were collected and used as crude HulFN-~. This material was irradiated by u.v. light (a 15 W Toshiba germicidal lamp) for 24 h at 0 °C to inactivate the Sendai virus which had been used as inducer. Its specific activity was 2.7 x 104 units/mg protein.
Crude IFN (total activity 2.1 × 104 IU) was applied to a Sephadex G-200 (Pharmacia) column (1.5 x 86.5 cm), and eluted with 0.05 M-Tris-HC1 pH 7.4 containing 1 M-NaC1 at a flow rate of 2.9 ml/h at 4 °C. The fraction size was 5 ml. Molecular weight markers used were blue dextran 2000, catalase (232K), ovalburnin (43K), chymotrypsinogen A (25K) and ribonuclease A (13.7K) (all from Pharmacia). Each fraction was assayed for IFN activity. The fractions in which IFN activity was found ranged from about 150K to 13K (Fig. 1) . The peak of IFN activity was detected in the 16K fraction Gel filtration on Sephadex G-200 was repeated three times, and fractions 15 to 18 of each preparation were pooled and concentrated by Minicon (Amicon). The IFN titre was then adjusted to 200 IU/ml, and the stability to pH 2 of the concentrated IFN preparations was tested by dialysis against glycine-HC1 buffer (pH 2) containing 0.1 M-NaC1 at 4 °C for 24 h, before dialysis against MEM for 24 h at 4 °C. Residual IFN activity was assayed on FL cells. Table 1 shows the IFN titre after pH 2 treatment. The preliminary experiment showed that fraction 21, which contained the main peak of crude IFN, was stable at pH 2 (data not shown), and that fractions 16, 19, 20 and 22 were also stable at pH 2. Purified HulFN-ct (sp. act. 2 x 106 IU/mg protein), kindly provided by Dr H. Nita, and purified HulFN-fl (sp. act. 1.3 x 108 IU/mg protein), kindly provided by Dr M. Nobahara, Mochida Pharmaceutical Co., Tokyo, Japan, were also stable at pH 2, although they had already been acidified at pH 2 before the process of purification. On the other hand, fractions 15, 17 and 18 were labile at pH 2, like purified HulFN-7 (sp. act. 5 x 107 IU/mg protein), kindly provided by Green Cross Inc., Osaka, Japan. The kinetics of the pH 2 inactivation was also examined. Fractions 15, 17 and 18, and HuIFN-c~ and -7 were treated at pH 2 for 1, 3, 6 and 20 h, and their IFN activities were determined. As shown in Table 2 , fractions 15, 17 and 18 and HuIFN-7 were partially inactivated by the treatment at pH 2 for 20 h. These results show that acid-labile IFNs were contained in crude HuIFN-c~. Then, their molecular weights were estimated by refractionation on a Sephadex G-200 column under the same conditions as described above. The IFN activity of each acid-labile component was found in nearly the same fractions as shown in Fig. 1 (data not shown) . The acidstable components, fractions 20 and 22, were completely neutralized by anti-HuIFN-c~ serum alone, as is the purified HuIFN-~. Fraction 15, one of the acid-labile components, was also neutralized with anti-HuIFN-c~ serum, whereas fractions 17 and 18, the other acid-labile components, were not neutralized with anti-HuIFN-c~ nor with anti-HuIFN-/? alone. These components were completely neutralized only with a mixture of anti-HuIFN-~ and (Balkwill et al., 1983) , C. parvum (Vil6ek et al., 1980) and Staphylococcus aureus (Gore et al., 1983; Ronnblom et al., 1983) . All these preparations were neutralized with antiHuIFN-~ serum alone, and they showed antiviral activity on bovine cells. We also examined the antiviral activity of the acid-labile IFNs on the bovine MDBK cells. The results show that MDBK cells are more sensitive to fractions 15, 17, 18, 20, 22 and HuIFN-~ than to HuIFN-fl and HuIFN-7 (Table 4) .
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It was confirmed in the present study that acid-labile IFN was found in the IFN preparation produced in human peripheral leukocytes infected with Sendal virus.
